Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis.
暂无分享,去创建一个
Jia Newcombe | Jackie Palace | Lars Fugger | M. Esiri | L. Fugger | J. Newcombe | J. Palace | M. Friese | Margaret M Esiri | Matthew J Craner | John S Tzartos | Manuel A Friese | M. Craner | J. Tzartos
[1] Nathalie Arbour,et al. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation , 2007, Nature Medicine.
[2] Kathleen M. Smith,et al. Development, cytokine profile and function of human interleukin 17–producing helper T cells , 2007, Nature Immunology.
[3] Hilde Cheroutre,et al. Reciprocal TH17 and Regulatory T Cell Differentiation Mediated by Retinoic Acid , 2007, Science.
[4] D. Jarrossay,et al. Surface phenotype and antigenic specificity of human interleukin 17–producing T helper memory cells , 2007, Nature Immunology.
[5] R. Nussenblatt,et al. TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1 , 2007, Nature Medicine.
[6] R. Locksley,et al. IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge , 2007, Nature Immunology.
[7] V. Kuchroo,et al. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation , 2007, Nature Medicine.
[8] L. Hennighausen,et al. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. , 2007, Immunity.
[9] C. Farina,et al. Astrocytes are active players in cerebral innate immunity. , 2007, Trends in immunology.
[10] P. Valdez,et al. Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis , 2007, Nature.
[11] Guang-Xian Zhang,et al. Increased IL-23p19 expression in multiple sclerosis lesions and its induction in microglia. , 2007, Brain : a journal of neurology.
[12] F. Powrie,et al. Interleukin-23 drives innate and T cell–mediated intestinal inflammation , 2006, The Journal of experimental medicine.
[13] D. Littman,et al. The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper Cells , 2006, Cell.
[14] X. Montalban,et al. The value of animal models for drug development in multiple sclerosis. , 2006, Brain : a journal of neurology.
[15] K. Mills,et al. A crucial role for interleukin (IL)-1 in the induction of IL-17–producing T cells that mediate autoimmune encephalomyelitis , 2006, The Journal of experimental medicine.
[16] S. Nakae,et al. IL-17 Plays an Important Role in the Development of Experimental Autoimmune Encephalomyelitis1 , 2006, The Journal of Immunology.
[17] H. Weiner,et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells , 2006, Nature.
[18] L. Presta,et al. Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. , 2006, The Journal of clinical investigation.
[19] R. J. Hocking,et al. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. , 2006, Immunity.
[20] R. Wu,et al. Up-Regulation of CC Chemokine Ligand 20 Expression in Human Airway Epithelium by IL-17 through a JAK-Independent but MEK/NF-κB-Dependent Signaling Pathway1 , 2005, The Journal of Immunology.
[21] M. Rovaris,et al. Immunological patterns identifying disease course and evolution in multiple sclerosis patients , 2005, Journal of Neuroimmunology.
[22] L. Fugger,et al. Autoreactive CD8+ T cells in multiple sclerosis: a new target for therapy? , 2005, Brain : a journal of neurology.
[23] E. Coccia,et al. Astrocytes Produce Dendritic Cell-Attracting Chemokines In Vitro and in Multiple Sclerosis Lesions , 2005, Journal of neuropathology and experimental neurology.
[24] F. Mihara,et al. Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis. , 2005, Brain : a journal of neurology.
[25] Ho‐Youn Kim,et al. Expression of IL-17 homologs and their receptors in the synovial cells of rheumatoid arthritis patients. , 2005, Molecules and cells.
[26] M. Goldman,et al. IL‐23 up‐regulates IL‐10 and induces IL‐17 synthesis by polyclonally activated naive T cells in human , 2005, European journal of immunology.
[27] T. Mcclanahan,et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation , 2005, The Journal of experimental medicine.
[28] Clare Baecher-Allan,et al. Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis , 2004, The Journal of experimental medicine.
[29] S. Nakae,et al. Suppression of Immune Induction of Collagen-Induced Arthritis in IL-17-Deficient Mice 1 , 2003, The Journal of Immunology.
[30] Stephen G Waxman,et al. Temporal Course of Upregulation of Nav1.8 in Purkinje Neurons Parallels the Progression of Clinical Deficit in Experimental Allergic Encephalomyelitis , 2003, Journal of neuropathology and experimental neurology.
[31] R. Ravid,et al. Cytokine, chemokine and growth factor gene profiling of cultured human astrocytes after exposure to proinflammatory stimuli , 2003, Glia.
[32] S. McColl,et al. A Role for Macrophage Inflammatory Protein-3α/CC Chemokine Ligand 20 in Immune Priming During T Cell-Mediated Inflammation of the Central Nervous System1 , 2003, The Journal of Immunology.
[33] B. Vainer,et al. Upregulation of Interleukin-12 and -17 in Active Inflammatory Bowel Disease , 2003, Scandinavian journal of gastroenterology.
[34] Jorge R. Oksenberg,et al. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis , 2002, Nature Medicine.
[35] W. Brück,et al. Interleukin-6 expression in human multiple sclerosis lesions , 2000, Neuroscience Letters.
[36] W. Brück,et al. Tumour necrosis factor alpha mRNA expression in early multiple sclerosis lesions: Correlation with demyelinating activity and oligodendrocyte pathology , 2000, Glia.
[37] T. Martin,et al. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. , 1999, The Journal of clinical investigation.
[38] P. Kivisäkk,et al. Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis , 1999, Multiple sclerosis.
[39] M. Esiri,et al. The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis. Identification and characterization of the primary demyelinating lesion. , 1997, Brain : a journal of neurology.
[40] M. Esiri,et al. Oligodendrocyte reactions and cell proliferation markers in human demyelinating diseases , 1994, Neuropathology and applied neurobiology.
[41] M. Cuzner,et al. Cytokine mRNA expression in inflammatory multiple sclerosis lesions: detection by non-radioactive in situ hybridization. , 1993, Cytokine.
[42] H. Weiner,et al. Immunohistochemical analysis of suppressor-inducer and helper-inducer T cells in multiple sclerosis brain tissue , 1987, Journal of Neuroimmunology.
[43] M. Cuzner,et al. Immunocytochemical characterisation of the immune reaction in the central nervous system in multiple sclerosis Possible role for microglia in lesion growth , 1986, Journal of the Neurological Sciences.
[44] H. Weiner,et al. Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions , 1986, Annals of neurology.
[45] M. Esiri,et al. Immunohistological analysis of T lymphocyte subsets in the central nervous system in chronic progressive multiple sclerosis , 1983, Journal of the Neurological Sciences.
[46] E. Reinherz,et al. Multiple sclerosis: distribution of T cell subsets within active chronic lesions. , 1983, Science.
[47] S. Mörk,et al. IN‐SITU CHARACTERIZATION OF MONONUCLEAR CELL INFILTRATES IN LESIONS OF MULTIPLE SCLEROSIS , 1982, Neuropathology and applied neurobiology.
[48] F. Sallusto,et al. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. , 2007, Nature immunology.
[49] D. Littman,et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. , 2006, Cell.
[50] L. Steinman,et al. The T lymphocyte in experimental allergic encephalomyelitis. , 1990, Annual review of immunology.
[51] J. Mussini,et al. [Immunology of multiple sclerosis]. , 1982, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris.